Wolverine Trading, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 1,636 shares of REGN stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,636

Previous 624 162.18%

Holding current value

$1.15 Million

Previous $655,000 162.44%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.04 Million - $1.22 Million	1,012 Added 162.18%	1,636 $1.72 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $3.99 Million - $4.83 Million	-4,513 Reduced 87.85%	624 $655,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $2.42 Million - $2.67 Million	2,685 Added 109.5%	5,137 $4.94 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.61 Million - $1.84 Million	-2,083 Reduced 45.93%	2,452 $2.15 Million
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $3.14 Million - $3.83 Million	4,535 New	4,535 $3.73 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $38.6 Million - $42 Million	54,753 Added 12248.99%	55,200 $39.8 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $256,564 - $323,771	447 New	447 $309,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $644,514 - $756,399	-1,083 Reduced 21.74%	3,898 $2.7 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.38 Million - $2.93 Million	-4,370 Reduced 46.73%	4,981 $3.2 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $2.94 Million - $3.49 Million	5,121 Added 121.06%	9,351 $5.67 Million
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $3.47 Million - $4.1 Million	-7,342 Reduced 63.45%	4,230 $2.31 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $4.81 Million - $5.91 Million	10,776 Added 1353.77%	11,572 $5.45 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $380,726 - $483,952	796 New	796 $381,000
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $1.96 Million - $2.88 Million	-5,833 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $595,684 - $818,156	2,173 Added 59.37%	5,833 $2.18 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $1 Million - $1.17 Million	3,660 New	3,660 $1 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $1.3 Million - $1.53 Million	-3,482 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $784,475 - $941,501	2,336 Added 203.84%	3,482 $1.26 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1.02 Million - $1.19 Million	-2,903 Reduced 71.7%	1,146 $463,000
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $883,664 - $1.16 Million	-2,464 Reduced 37.83%	4,049 $1.52 Million
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $2.81 Million - $3.28 Million	6,513	6,513 $2.91 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Regeneron Pharmaceuticals, Inc. Transaction History